Entero Healthcare Solutions Share Price
Sector:
1194.75 -11.45 (-0.95%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1187.25
Today’s High
1206.55
52 Week Low
1009.00
52 Week High
1583.00
Key Metrics
- Market Cap (In Cr) 5208.91
- Beta -
- Div. Yield (%) 0
- P/B 3.03
- TTM P/E 52.13
- Peg Ratio 0.36
- Sector P/E 23.38
- D/E 0
- Open Price 1206.55
- Prev Close 1206.2
Entero Healthcare Solutions Analysis
Price Analysis
-
1 Week-1.03%
-
3 Months-0.36%
-
6 Month-17.74%
-
YTD-15.28%
-
1 Year17.78%
Risk Meter
- 45% Low risk
- 45% Moderate risk
- 45% Balanced Risk
- 45% High risk
- 45% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 1
- 1
- 1
- 1
- Hold
- 1
- 1
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 3
- 3
- 2
- 2
Entero Healthcare Solutions News
Q4 results today: LIC, Info Edge, Minda Corp, Supriya Lifesciences, Bosch, more
2 min read . 27 May 2025TVS Motor, PNB Housing among 14 stocks that can double in 3 years: DAM Capital
5 min read . 09 Jan 2025Adani Enterprises, HAL, and more: Jefferies initiates coverage on 13 stocks
7 min read . 27 May 2024Entero Healthcare Solutions Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 5095.78
- Selling/ General/ Admin Expenses Total
- 199.04
- Depreciation/ Amortization
- 30.69
- Other Operating Expenses Total
- 115.72
- Total Operating Expense
- 4954.92
- Operating Income
- 140.86
- Net Income Before Taxes
- 138.74
- Net Income
- 94.82
- Diluted Normalized EPS
- 21.76
- Period
- 2025
- Total Assets
- 2702.52
- Total Liabilities
- 978.37
- Total Equity
- 1724.15
- Tangible Book Valueper Share Common Eq
- 298.03
- Period
- 2025
- Cashfrom Operating Activities
- -64.51
- Cashfrom Investing Activities
- 219.8
- Cashfrom Financing Activities
- -73.66
- Net Changein Cash
- 81.63
- Period
- 2024
- Total Revenue
- 3922.31
- Selling/ General/ Admin Expenses Total
- 170.08
- Depreciation/ Amortization
- 25.02
- Other Operating Expenses Total
- 64.44
- Total Operating Expense
- 3835.48
- Operating Income
- 86.83
- Net Income Before Taxes
- 35.56
- Net Income
- 39.11
- Diluted Normalized EPS
- 10.81
- Period
- 2024
- Total Assets
- 2344.98
- Total Liabilities
- 706.92
- Total Equity
- 1638.06
- Tangible Book Valueper Share Common Eq
- 331.5
- Period
- 2024
- Cashfrom Operating Activities
- -35.53
- Cashfrom Investing Activities
- -705.12
- Cashfrom Financing Activities
- 862.94
- Net Changein Cash
- 122.28
- Period
- 2023
- Total Revenue
- 3300.21
- Selling/ General/ Admin Expenses Total
- 132.92
- Depreciation/ Amortization
- 24.24
- Other Operating Expenses Total
- 67.16
- Total Operating Expense
- 3260.44
- Operating Income
- 39.77
- Net Income Before Taxes
- -3.69
- Net Income
- -11.56
- Diluted Normalized EPS
- -2.66
- Period
- 2023
- Total Assets
- 1308.73
- Total Liabilities
- 713.7
- Total Equity
- 595.03
- Tangible Book Valueper Share Common Eq
- 97.52
- Period
- 2023
- Cashfrom Operating Activities
- -45.32
- Cashfrom Investing Activities
- -48.6
- Cashfrom Financing Activities
- 72.76
- Net Changein Cash
- -21.15
- Period
- 2022
- Total Revenue
- 2522.07
- Selling/ General/ Admin Expenses Total
- 118.5
- Depreciation/ Amortization
- 19.75
- Other Operating Expenses Total
- 62.62
- Total Operating Expense
- 2517.38
- Operating Income
- 4.68
- Net Income Before Taxes
- -19.81
- Net Income
- -29.92
- Diluted Normalized EPS
- -6.88
- Period
- 2022
- Total Assets
- 1125.98
- Total Liabilities
- 564.94
- Total Equity
- 561.04
- Tangible Book Valueper Share Common Eq
- 93.43
- Period
- 2022
- Cashfrom Operating Activities
- -35.27
- Cashfrom Investing Activities
- -161.73
- Cashfrom Financing Activities
- 211.19
- Net Changein Cash
- 14.19
- Period
- 2021
- Total Revenue
- 1779.74
- Selling/ General/ Admin Expenses Total
- 79.86
- Depreciation/ Amortization
- 16.28
- Other Operating Expenses Total
- 36.8
- Total Operating Expense
- 1774.47
- Operating Income
- 5.27
- Net Income Before Taxes
- -10.84
- Net Income
- -15.54
- Diluted Normalized EPS
- -3.57
- Period
- 2021
- Total Assets
- 833.79
- Total Liabilities
- 348.42
- Total Equity
- 485.37
- Tangible Book Valueper Share Common Eq
- 89.96
- Period
- 2021
- Cashfrom Operating Activities
- -68.68
- Cashfrom Investing Activities
- -30.87
- Cashfrom Financing Activities
- 88.71
- Net Changein Cash
- -10.84
- Period
- 2020
- Total Revenue
- 1349.62
- Selling/ General/ Admin Expenses Total
- 60.85
- Depreciation/ Amortization
- 11.5
- Other Operating Expenses Total
- 24.2
- Total Operating Expense
- 1337.65
- Operating Income
- 11.98
- Net Income Before Taxes
- 3.87
- Net Income
- 0.94
- Diluted Normalized EPS
- 0.22
- Period
- 2020
- Total Assets
- 749.22
- Total Liabilities
- 326.54
- Total Equity
- 422.68
- Tangible Book Valueper Share Common Eq
- 76.04
- Period
- 2020
- Cashfrom Operating Activities
- -36.52
- Cashfrom Investing Activities
- -203.28
- Cashfrom Financing Activities
- 216.81
- Net Changein Cash
- -22.99
- Period
- 2025-03-31
- Total Revenue
- 1339.06
- Selling/ General/ Admin Expenses Total
- 52.02
- Depreciation/ Amortization
- 8.49
- Other Operating Expenses Total
- 29.84
- Total Operating Expense
- 1298.64
- Operating Income
- 40.42
- Net Income Before Taxes
- 37.23
- Net Income
- 25.69
- Diluted Normalized EPS
- 5.9
- Period
- 2025-03-31
- Total Assets
- 2702.52
- Total Liabilities
- 978.37
- Total Equity
- 1724.15
- Tangible Book Valueper Share Common Eq
- 298.03
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -64.51
- Cashfrom Investing Activities
- 219.8
- Cashfrom Financing Activities
- -73.66
- Net Changein Cash
- 81.63
- Period
- 2024-12-31
- Total Revenue
- 1359
- Selling/ General/ Admin Expenses Total
- 53.39
- Depreciation/ Amortization
- 8.1
- Other Operating Expenses Total
- 30
- Total Operating Expense
- 1317.08
- Operating Income
- 41.91
- Net Income Before Taxes
- 39.44
- Net Income
- 25.44
- Diluted Normalized EPS
- 5.84
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1300.69
- Selling/ General/ Admin Expenses Total
- 50.07
- Depreciation/ Amortization
- 7.49
- Other Operating Expenses Total
- 29.65
- Total Operating Expense
- 1265.74
- Operating Income
- 34.96
- Net Income Before Taxes
- 34.78
- Net Income
- 23.62
- Diluted Normalized EPS
- 5.42
- Period
- 2024-09-30
- Total Assets
- 2652.9
- Total Liabilities
- 970.08
- Total Equity
- 1682.82
- Tangible Book Valueper Share Common Eq
- 290.47
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -112.73
- Cashfrom Investing Activities
- 115.67
- Cashfrom Financing Activities
- -69.94
- Net Changein Cash
- -67
- Period
- 2024-06-30
- Total Revenue
- 1097.04
- Selling/ General/ Admin Expenses Total
- 43.57
- Depreciation/ Amortization
- 6.61
- Other Operating Expenses Total
- 26.23
- Total Operating Expense
- 1073.47
- Operating Income
- 23.57
- Net Income Before Taxes
- 27.3
- Net Income
- 20.08
- Diluted Normalized EPS
- 4.62
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1034.18
- Selling/ General/ Admin Expenses Total
- 37.94
- Depreciation/ Amortization
- 7.14
- Other Operating Expenses Total
- 25.8
- Total Operating Expense
- 1012.44
- Operating Income
- 21.73
- Net Income Before Taxes
- 13.56
- Net Income
- 20.97
- Diluted Normalized EPS
- 14.76
- Period
- 2024-03-31
- Total Assets
- 2344.98
- Total Liabilities
- 706.92
- Total Equity
- 1638.06
- Tangible Book Valueper Share Common Eq
- 331.5
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -35.53
- Cashfrom Investing Activities
- -705.12
- Cashfrom Financing Activities
- 862.94
- Net Changein Cash
- 122.28
- Period
- 2023-12-31
- Total Revenue
- 992.63
- Selling/ General/ Admin Expenses Total
- 39.89
- Depreciation/ Amortization
- 5.99
- Other Operating Expenses Total
- 21.71
- Total Operating Expense
- 970.03
- Operating Income
- 22.61
- Net Income Before Taxes
- 8.32
- Net Income
- 6.78
- Diluted Normalized EPS
- 1.56
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Entero Healthcare Solutions Technical
Moving Average
SMA
- 5 Day1214.96
- 10 Day1233.31
- 20 Day1344.75
- 50 Day1300.58
- 100 Day0
- 300 Day0
Entero Healthcare Solutions Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Avalon Technologies
- 821.7
- -23.6
- -2.79
- 1074
- 426.25
- 5477.94
- Jana Small Finance Bank
- 506.55
- -14.6
- -2.8
- 760.85
- 364
- 5299.94
- Entero Healthcare Solutions
- 1194.75
- -11.45
- -0.95
- 1583
- 1009
- 5208.91
- Bondada Engineering
- 456.4
- 8.6
- 1.92
- 753.98
- 330
- 5021.65
- Yatharth Hospital Tra Ca Ser
- 521.25
- -8.7
- -1.64
- 692.85
- 345.35
- 5046.76
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Avalon Technologies
- 89.61
- 9.19
- 14.64
- 5.28
- Jana Small Finance Bank
- 10.92
- 1.33
- 14.75
- 13.23
- Entero Healthcare Solutions
- 55.23
- 3.03
- 1.77
- 0.55
- Bondada Engineering
- 45.04
- 11.39
- -
- -
- Yatharth Hospital Tra Ca Ser
- 35.99
- 3.18
- 17.97
- 13.87
Entero Healthcare Solutions Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 27-May-25
- Audited Results
- 12-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 14-Aug-24
- Quarterly Results
- 29-May-24
- Audited Results
- 08-Mar-24
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 28-Aug-24
- 05-Aug-24
- AGM



